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Abstract The 70-kDa peroxisomal membrane protein 
(PMP 70), adrenoleukodystrophy protein (ALDP) and adreno-
leukodystrophy-related protein (ALDRP) belong to the ATP-
binding transporter family, share a structure of half-transporters 
and are localized in the peroxisomal membrane of mammals. It 
was suggested that these proteins may heterodimerize to form 
functional transporters. The expression of the three genes was 
examined in various tissues of control or fenofibrate (a 
peroxisome proliferator)-treated rats using Northern and im-
muno-blotting techniques. The patterns of tissue expression were 
distinct for the three genes. Upon treatment, expression of the 
ALD gene was not altered while that of the PMP 70 and ALDR 
genes was strongly increased in intestine and liver, respectively. 
The absence of coordinated expression excludes that the three 
transporters function as exclusive and obligatory partners. We 
also report for the first time that the ALDR gene is inducible in 
rodents and that the corresponding mRNA is different in length 
in rat (3.0 and 5.5 kb) and in mouse and human (4.2 kb). 
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1. Introduction 
Several ATP-binding cassette (ABC) transporter proteins 
are associated with the mammalian peroxisome membrane. 
These molecules include the peroxisomal membrane protein 
of 70 kDa (PMP 70) [1], adrenoleukodystrophy protein 
(ALDP) [2] and adrenoleukodystrophy-related protein 
(ALDRP) [3]. In Zellweger's syndrome, a genetically hetero-
geneous disorder of peroxisome biogenesis, some patients 
have defects in the locus encoding PMP 70 [4]. Similarly, 
mutations in the ALD gene are responsible for a severe X-
chromosome linked neurodegenerative disorder, adrenoleuko-
dystrophy [2]. Unlike individuals afflicted with Zellweger's 
syndrome, patients with ALD possess apparently intact per-
oxisomes. ALD is biochemically characterized by a decrease 
in the activity of peroxisomal lignoceroyl-CoA ligase (very-
long-chain acyl-CoA synthetase) [5,6]. Although until now 
the ALDR gene has not been found to be involved in perox-
isomal disorders, it might be a candidate of the modifier genes 
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predicted to account for the tremendous phenotypic variabil-
ity of ALD [7] or one of the genes implicated in the comple-
mentation groups of Zellweger's syndrome [8]. 
All functional ABC transporters share an organization with 
four 'core' domains that can be expressed as separate poly-
peptides or fused together in larger, multidomain proteins [9]. 
Because PMP 70, ALDP and ALDRP display a half trans-
porter structure, a homo- or heterodimer of these transporters 
therefore needs to be formed to constitute a functional trans-
porter. It has been suggested that PMP 70 and ALDP [10] or 
ALDRP [3] could interact to form an active heterodimer. 
Recently, the function of two genes encoding peroxisomal 
membrane ABC proteins, probably ortholog of ALDP, first 
called YKL 74 lp [11] and Pxalp [12] and now called Patlp 
and Pat2p [13] or Pxalp and Pxa2p [14], has been described in 
Saccharomyces cerevisiae. Patlp and Pat2p heterodimerize to 
form a functional transporter that imports activated long-
chain fatty acids from the cytosolic pool into the peroxisome 
that is the exclusive site of P-oxidation in yeasts. By inference, 
the authors suggested that the human ALDP might be in-
volved in the uptake of activated very-long-chain fatty acids 
into human peroxisomes. Nevertheless, neither the dimeric 
structure of the PMP 70, ALDP and ALDRP transporters, 
nor their function or their substrates, are elucidated in mam-
mals. 
In this work, expression of the PMP 70, ALD and ALDR 
genes was studied in a variety of tissues from rats treated with 
fenofibrate, a potent peroxisomal proliferator in rodents. 
Comparison of the expression profiles does not support the 
hypothesis of a heterodimeric form of the three known per-
oxisomal ABC transporters in mammals. 
2. Materials and methods 
2.1. Chemicals 
Fenofibrate (2-[4-(4-chlorobenzoyl) phenoxy]-2-methyl propanoic 
acid 1 -methylethyl ester) was a gift from Fournier SCA, Dijon, 
France. Nycodenz and Maxidenz were from Nycomed A/S, Oslo, 
Norway. 
2.2. Animals 
Male Wistar rats (250 g b.wt.) were obtained from IFFA-CREDO, 
L'Arbresle, France. They were kept at a temperature of 22°C with 
equal periods of darkness and light and had free access to water and 
food. Treated animals were fed a diet supplemented with 0.3% fenofi-
brate. The diet was prepared by spraying chow pellets with the hypo-
lipidemic drug dissolved in acetone and, then, by evaporating acetone 
at room temperature overnight. 
2.3. Isolation of peroxisomes 
Peroxisomes of liver from control or fenofibrate-treated rats were 
purified by a discontinuous Nycodenz gradient according to Cher-
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kaoui-Malki and coworkers [15]. Peroxisomal membranes were pre-
pared using the sodium carbonate procedure [16]. 
2.4. Northern blot analysis 
Total RNA was isolated from fresh or frozen, saline-washed tissues 
by the method of Chomczynski and Sacchi [17]. Poly(A)+ RNA were 
prepared as described by Celano and coworkers [18], electrophoresed 
and transferred onto Amersham Hybond-N membranes. Membranes 
were prehybridized in Rapid-Hyb buffer (Amersham) for 2 h at the 
hybridization temperature. Hybridization was carried out for 2 h at 
65°C in the same buffer containing freshly-labelled cDNA probe. 
Probes were full-length cDNAs for human PMP 70, mouse ALDP 
and ALDRP [3,4,19]. Rat palmitoyl-CoA oxidase (AOX) cDNA was 
a gift of Dr. T. Osumi [20]. Rat glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) cDNA (provided by Dr. W.A. Schulz) [21] was used 
as a control probe to check the amount of RNA loaded. Probes were 
labelled by random priming using [o>32P]dATP [22]. The labelled 
probes were purified on ProbeQuant G-50 Micro Columns (Pharma-
cia). The blots were washed twice 15 min in 5XSSC, 0.1% SDS at the 
room temperature, then 2X 15 min in 1 XSSC, 0.1% SDS at the hy-
bridization temperature and finally once 15 min in 0.1 XSSC, 0.1% 
SDS at the hybridization temperature. The membranes were exposed 
to Kodak BioMax MS films at -70°C for 1-24 h. 
2.5. Isolation of a rat ALDR exonic sequence 
PCR primers from the mouse ALDR region corresponding to large 
ALD exon 1 [23] were used to amplify a 500 bp segment of the rat 
ALDR gene from rat genomic DNA, as described in [3]. The primers 
were 5'-TGGACCAGATCCGGTGCTGCT-3' and 5'-TACTAAGC-
GAGTTCTAAAGGC-3'. The PCR fragment was extracted using 
phenol/chloroform and directly sequenced using its own primers and 
fluorescent dideoxynucleotides. 
2.6. Western blot analysis 
Proteins of purified peroxisomes and peroxisomal membranes from 
rat liver were subjected to SDS-PAGE [24]. The proteins were then 
electrotransferred onto an Immobilon-P membrane (Millipore), incu-
bated with polyclonal rabbit antibody and subsequently with goat 
anti-rabbit IgG antibody conjugated to alkaline phosphatase (Sigma). 
2.7. Preparation of polyclonal antibodies 
Peroxisomal membrane proteins obtained from liver of fenofibrate-
treated rats were separated by SDS-PAGE. The polypeptide band 
corresponding to PMP 70 was cut-out and extracted from the gel 
by electroelution in 50 mM ammonium bicarbonate containing 1% 
SDS, using a 422 Electro-eluter (BioRad). PMP 70 was again puri-
fied under similar conditions and, then, injected into rabbits to raise 
serum antibodies. A synthetic peptide was generated that corresponds 
to the predicted amino acid residues 700-736 in mouse ALDP. The 
peptide was coupled to bovine serum albumin, and antiserum was 
raised in rabbits. 
2.8. Protein concentrations 
Protein contents were determined using the Bio-Rad microassay 
with bovine serum albumin as the standard. 
3. Results 
3.1. Expression of the ALD and PMP 70 genes 
Northern blot analysis of poly(A)+ R N A prepared from 
various tissues of adult rats was carried out using full-length 
cDNAs corresponding to the human PMP 70, mouse ALD 
and ALDR genes. Fig. 1A shows that ALD m R N A was de-
tected more strongly in intestine, heart, lung and spleen than 
in skeletal muscle and liver, and weakly in brain and kidney. 
Fenofibrate treatment did not affect the level of ALD m R N A . 
However, as expected the level of peroxisomal acyl-CoA ox-
idase m R N A used as a marker of peroxisomal proliferation 
was strongly enhanced in liver and intestine by fenofibrate 
treatment (Fig. ID) . The PMP 70 gene was found to be ex-
pressed especially in liver, more weakly in kidney and intestine 
and only slightly in other tissues (Fig. IB). The level of PMP 
70 m R N A was increased in liver and intestine when rats were 
treated with fenofibrate. 
Expression of the ALD and PMP 70 genes were also ex-
amined at the protein level in post-nuclear homogenates from 
control and fenofibrate-treated rat tissues by using polyclonal 
anti-mouse A L D P and anti-rat P M P 70 antibodies. Only a 
fine band at about 75 k D a consistent with the molecular mass 
ALD 4.2 kb 
PMP70 3.6 kb 
ALDR 
< 5.5kb 
< 3.0 kb 
AOX 3.9 kb 
GAPDH 1.4 kb 
Fig. 1. mRNA expression of the ALD, PMP 70 and ALDR genes in rat tissues. The Northern blot containing 5 u,g of poly(A)+ RNA isolated 
from tissues of control (lane c) and fenofibrate-treated (lane f) rats (skeletal muscle (Sk), heart (H), brain (B), lung (Lu), liver (Li), kidney (K), 
intestine (In) and spleen (Sp)) was hybridized as described in Section 2. Probes were mouse ALD cDNA, human PMP 70 cDNA, mouse 
ALDR cDNA, rat acyl-CoA oxidase (AOX) cDNA. Rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA probe was used as a con-
trol for the loaded amount of RNA. 
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< 43 kDa 
A B 
Fig. 2. Western blot analysis of proteins in purified peroxisomes and peroxisomal membranes. Proteins of purified peroxisomes (8 ug) (lanes P) 
and proteins of peroxisomal membranes (14 ug) (lanes PMP) from liver of control (c) and fenofibrate-treated (f) rats. The 100-fold diluted se-
rum against ALDP (A) or PMP 70 (B) was used as the first antibody, and the second antibody was 1000-fold diluted goat alkaline phospha-
tase-conjugated anti-rabbit IgG. Visualization was carried out using 5-bromo-3-chloro-indolyl phosphate/nitroblue tetrazolium as the substrate. 
The 43-kDa band detected in (B) was probably a result of proteolysis of PMP 70 [1]. 
of ALDP could be detected in most tissues, and the fenofi-
brate treatment had apparently no effect (results not shown). 
PMP 70 was detected especially in liver and kidney and was 
enhanced by the fenofibrate treatment (results not shown). 
When purified peroxisomes and peroxisomal membrane pro-
teins from liver were examined, Fig. 2 shows clearly that fe-
nofibrate did not alter the ALDP level whereas it strongly 
increased the PMP 70 level. 
3.2. Expression of the ALDR gene 
As far as the ALDR gene is concerned, the 4.2-kb mRNA 
normally found in mouse and human tissues was not detected 
in rat tissues using mouse ALDR cDNA as a probe (Fig. 1C). 
However, two other transcripts at about 3.0 and 5.5 kb were 
strongly detected in skeletal muscle and brain. The 3.0-kb 
mRNA alone was detected in lung and heart. In liver, the 
3.0-kb mRNA level was strongly enhanced by fenofibrate. 
When mice were treated with fenofibrate, a strong increase 
in the 4.2 kb ALDR mRNA was observed in liver but not 
in intestine and kidney (data not shown). Interestingly, the 
3.0- and 5.5-kb mRNA species were also observed in the 
mouse brain besides the predominant signal at 4.2 kb corre-
sponding to ALDR mRNA (Fig. 3A). 
Using primers within putative mouse ALDR exon 1, a frag-
ment of 500 bp was amplified by PCR from rat genomic 
DNA. The rat amplicon was very similar in nucleic sequence 
(95% identity) to the corresponding sequence of the mouse 
ALDR cDNA (data not shown). It was used as a probe in 
Northern blot analysis of rat and mouse poly(A)+ RNA 
under the same conditions as those described for Fig. 1 
Whereas the 4.2-kb ALDR mRNA was strongly expressed 
in the mouse brain, it was not detected in all the rat tissues 
examined (results not shown) including the brain (Fig. 3B). 
On the other hand, the 3.0- and 5.5-kb mRNA were again 
detected in the rat tissues in a similar pattern as already ob-
served in Fig. 1C, except in the lung in which the 5.5-kb 
transcript was also detected (results not shown). However, 
using the rat ALDR probe, the intensity of the mRNA de-
tected at 3.0 and 5.5 kb in some rat tissues was comparable 
with that of the 4.2-kb ALDR mRNA in mouse as shown in 
Fig. 3A,B for the brain. Futhermore, fenofibrate induction 
was again observed only in the liver (results not shown). 
Southern blot experiments performed using either mouse 
ALDR cDNA or a rat ALDR PCR fragment as the probe 
and mouse and rat genomic DNA confirmed the presence of 
the ALDR gene in both rodents (results not shown). 
4. Discussion 
ALDP and PMP 70 are 'half transporter' versions with 
one hydrophobic and one hydrophilic domains, share a 
38.5% amino-acid identity, and both have a peroxisomal 
membrane location. It was suggested that ALDP and 
PMP 70 heterodimerize to form a functional transporter 
[10]. However, Northern blot analysis of the ALD and 
PMP 70 genes had shown distinct expression patterns in 
4.2 kb 
Fig. 3. Northern blot analysis of ALDR mRNA in rat and mouse tissues. The Northern blots of poly(A)+ RNA (5 ug per each lane) were pre-
pared from brain of control (c) mice (mB) and control (c) and fenofibrate-treated (f) rats (rB). A: The membrane was hybridized using the 
full-length mouse ALDR cDNA as the probe. B: The membrane was hybridized using the 500-pb PCR fragment amplified from rat genomic 
DNA, as the probe. 
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mouse [3]. These observations were confirmed by the present 
results obtained in the rat by Northern and Western blot 
analyses. Moreover, we observed no effects of a fenofibrate 
treatment on the ALD mRNA level in the eight rat tissues 
examined whereas fenofibrate induction of the PMP 70 gene 
was found in liver and intestine. An increase in the PMP 70 
mRNA had already been pointed out in the liver of rats 
treated with fenofibrate [25], ciprofibrate [25] or diethylhex-
ylphtalate [1]. Finally, different spatial and temporal expres-
sion of ALD and PMP 70 mRNA during post-natal develop-
ment has been demonstrated using in situ hybridization 
histochemistry in rat brain [26]. Absence of coordinated ex-
pression of the PMP 70 and ALD genes in different tissues 
and in response to peroxisome proliferators indicates that 
these two genes are regulated by different mechanisms. Our 
results and those from other authors taken together suggest 
therefore that ALDP and PMP 70 are unlikely to function as 
exclusive and obligatory partners in the peroxisomal mem-
brane. 
Because the ALDR gene is presently the closest known ho-
mologue to the ALD gene (66% amino-acid identity), it was 
suggested that ALDRP may also interact with ALDP or 
PMP 70 to form an active heterodimer [3]. Recently, Lom-
bart-Platet and coll. [3] showed that the expression patterns of 
the ALDR, ALD and PMP 70 genes were distinct in some 
mouse tissues and cell lines, as revealed by Northern blotting. 
Similar conclusions can be drawn from the present results 
obtained in the rat. For example in the brain of rat, and of 
mouse as well [3], the ALDR gene is strongly expressed where-
as the ALD and PMP 70 genes are weakly expressed. Fur-
thermore, fenofibrate appears to alter the expression of the 
ALDR gene in the liver, but not in the intestine, of the rat 
and mouse. All together, the data are not in favor of func-
tional heterodimerization of the members of the peroxisomal 
ABC protein subfamily but rather suggest that ALDP, 
ALDRP and PMP 70 may be specialized for function in spe-
cific tissue types. 
Interestingly, the 4.2-kb ALDR mRNA strongly expressed 
in mouse brain [3] was not expressed in all of the rat tissues 
tested. Instead, two other transcripts (3.0 and 5.5 kb) were 
found to be expressed in the rat. These two transcripts were 
also expressed in mouse brain, but weakly. The hybridization 
conditions used (high stringency) suggest that these two 
ALDR homologous mRNA are closely related to the 4.2-kb 
ALDR mRNA. The ALDR gene actually appears to be 
present in rat as shown by PCR amplification of putative 
ALDR exon 1 and Southern blot hybridization. One of the 
two additional transcripts at least (the 3.0-kb mRNA more 
probably) corresponds to the ALDR mRNA in rat and could 
arise from use of multiple transcription or polyadenylation 
sites. Heterogeneity in ALDR mRNA size may be relevant 
to the regulation of this gene. Indeed, it should be noticed 
that in rat liver, only the 3.0-kb ALDR transcript is markedly 
increased following fenofibrate treatment. The biological sig-
nificance of this phenomenon and its possible relevance to the 
control of expression of this gene are the subject of further 
investigations. 
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